Quintiles Transitional Holdings (Q) 63.31 $Q
Quintiles Transnational Holdings (Q) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 10:50AM CST
Q: 63.31 (+0.06)
Quintiles Transnational Holdings beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 5:12AM CST
Q: 63.31 (+0.06)
Quintiles 4th Quarter 2014 Results and 2015 Guidance
Business Wire - Thu Feb 12, 5:01AM CST
--9.3% constant currency service revenue growth compared to the fourth quarter of 2013
Q: 63.31 (+0.06)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:30PM CST
NLSN: 45.59 (+2.02), RTIX: 5.54 (+0.19), AAP: 150.16 (-1.26), JAH: 51.18 (+0.18), LMNS: 10.80 (+0.57), THS: 80.00 (-1.57), RWLK: 17.40 (-0.77), CAB: 53.55 (+1.23), FAF: 37.00 (+0.10), HSP: 87.35 (unch), PNK: 25.64 (-0.35), MFA: 7.89 (unch), SPW: 87.37 (-2.81), MFC: 17.31 (+0.27), HIMX: 8.04 (+0.28), LNCE: 30.72 (-0.25), TIME: 24.84 (+0.35), AVP: 9.08 (+0.39), INCY: 75.94 (+0.28), NNN: 41.00 (+0.20), NWE: 53.61 (-0.85), COR: 48.08 (+1.08), MHFI: 102.19 (unch), NCI: 14.99 (-0.01), BWA: 60.17 (-1.21), HERO: 0.92 (+0.02), NRP: 7.86 (-0.45), STC: 37.85 (+0.23), AB: 27.17 (+0.47), CPLA: 65.23 (-1.37), TU: 34.83 (+0.01), IFF: 116.96 (+2.19), GNC: 48.11 (-0.55), MINI: 40.62 (-0.83), ACOR: 36.14 (-0.51), CVE: 19.42 (-0.29), SNI: 73.00 (+0.39), CCE: 43.69 (-0.66), K: 63.20 (-0.10), DPS: 76.95 (-1.35), BG: 82.22 (+1.78), AAWW: 48.01 (+0.44), Q: 63.31 (+0.06), SHPG: 239.82 (+6.11), MANU: 17.20 (-0.21), MPEL: 27.54 (+0.78), APA: 67.05 (+2.47), DBD: 35.82 (+1.07), MPW: 14.64 (+0.14), HE: 33.14 (-0.22), RYN: 28.02 (-1.15), CS: 23.65 (+0.23), PDS: 6.04 (+0.12), ANR: 1.27 (+0.03), SON: 46.65 (-0.79), SKYW: 13.84 (+1.88), LPNT: 69.04 (-0.06), RDN: 16.10 (-0.43), MDWD: 7.22 (+0.17), SCOR: 53.35 (-1.10), FLO: 21.68 (+0.38)
Quintiles Works with NFL to Track Injuries and Understand Trends
Business Wire - Tue Feb 10, 7:01AM CST
Quintiles, the world's largest biopharmaceutical services company, is working with the National Football League (NFL) to track player injuries and understand trends in injury occurrence.
Q: 63.31 (+0.06)
Quintiles Continues Governance Transition Plan
Business Wire - Fri Feb 06, 7:00AM CST
Quintiles Transnational Holdings Inc. ("Quintiles" or the "Company"
(NYSE: Q) announced today that its Board and principal shareholders have reached agreement on a governance plan to transition the Company's Board of Directors and its committees to comply with NYSE criteria as a non-controlled company.
Q: 63.31 (+0.06)
Dr. John Leonard Elected to Quintiles Transnational Holdings Inc. Board of Directors
Business Wire - Fri Feb 06, 7:00AM CST
Quintiles Transnational Holdings Inc. ("Quintiles" or the "Company" (NYSE: Q) announced today that Dr. John Leonard, MD, has been appointed to its Board of Directors, effective immediately. Dr. Leonard will also serve as a member of the Audit and Governance Committees of the Board.
Q: 63.31 (+0.06)
IBB Is +34% For 1 Year And +7.31% For 2015 - But What Are The Risks?
Reuben Sushman - at Seeking Alpha - Fri Jan 30, 9:07AM CST
VRTX: 113.66 (+4.03), Q: 63.31 (+0.06), IBB: 323.46 (+3.04), CELG: 115.88 (+0.16)
Icon, A Leader In Its Industry, Builds A Base
at Investor's Business Daily - Tue Jan 27, 5:12PM CST
New drugs require clinical trials and those trials increasingly have taken place on an international stage. Many top drug developers outsource an increasing share of trials to companies like Icon (ICLR). Based in Dublin, Icon is one of the top five...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), LH: 116.90 (+0.06), ICLR: 60.01 (+0.38), CVD: 107.08 (+0.05)
Investigator Initiated Trials is Topic of New Handbook Sponsored by Quintiles
Business Wire - Thu Jan 22, 9:00PM CST
Quintiles today announced the launch of a handbook to guide physicians in the conduct of investigator initiated clinical trials. Top clinical researchers from academia and industry across Asia-Pacific joined Quintiles' experts in contributing to and editing the handbook, which Quintiles sponsored as part of its ongoing efforts to enhance clinical research globally and create a healthier world.
Q: 63.31 (+0.06)
Quintiles' Fourth Quarter 2014 Earnings Call Scheduled for Thursday, February 12th
Business Wire - Mon Jan 19, 7:00AM CST
Quintiles Transnational Holdings Inc. (NYSE:Q) will release its fourth-quarter 2014 financial results Thursday, February 12, 2015 prior to its quarterly earnings call at 8:00 a.m. EST.
Q: 63.31 (+0.06)
Expression Analysis Announces 2014 Grant Winners
Business Wire - Thu Jan 15, 7:00AM CST
Expression Analysis (EA), a Quintiles company, today announced the winners of a grant program that provides scientists with leading-edge products and services to advance genomics research. In this sixth year of the program, EA and co-sponsor, Illumina, awarded two fully funded research grants to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded (FFPE) tumor samples - a largely untapped data pool that can help enhance researchers' understanding of cancer biology.
Q: 63.31 (+0.06)
Insider Trading Alert - AHS, Q And VLGEA Traded By Insiders
at The Street - Mon Jan 12, 9:15AM CST
Stocks with insider trader activity include AHS, Q and VLGEA
Q: 63.31 (+0.06), AHS: 20.56 (-0.34), VLGEA: 28.17 (-0.08)
Quintiles Transitional (Q) Stock Gains on Mixed Analyst Report
at The Street - Fri Jan 02, 8:38AM CST
Quintiles Transitional Holdings (Q) shares are up after analysts at Keybanc reiterated their 'hold' rating ahead of the release of the company's 2015 guidance.
Q: 63.31 (+0.06)
Will Health Yield Wealth For Recent IPO INC Research?
at Investor's Business Daily - Wed Dec 31, 3:53PM CST
What's the prescription for stirring up investor enthusiasm in the IPO market? INC Research Holdings (INCR) may have found the answer. INC is a contract research organization, or CRO, which provides phase one to phase four clinical development...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), INCR: 24.19 (-0.45), ILMN: 198.54 (+1.81), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
Recent IPO PRA Health Sciences Finds Growth In Buyout
at Investor's Business Daily - Tue Dec 30, 4:16PM CST
Recent IPO PRA Health Sciences may have gotten a tepid reception from investors out of the gate. But the global contract research organization, or CRO, has been making up for lost time ever since. PRA (PRAH) went public in November at $18, below...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), INCR: 24.19 (-0.45), ILMN: 198.54 (+1.81), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
Grab 2015 Gains With These 5 Health Care Trades: Intuitive Surgical, Receptos and More
at The Street - Tue Dec 30, 7:32AM CST
The health care sector is showing strong vitals as we head into 2015. Here's a closer technical look at five health stocks that look ready for breakout gains.
ISRG: 510.73 (+3.02), Q: 63.31 (+0.06), THC: 44.30 (+0.75), RCPT: 115.83 (-0.66), BRKR: 18.77 (-0.02)
Renaissance Capital's 2014 U.S. IPO Annual Review
Renaissance Capital IPO Research - at Seeking Alpha - Fri Dec 26, 3:53AM CST
2014 U.S. IPO Market Has Another Record Year Over the last year, the US IPO market set a 14-year record against a mostly low-volatility backdrop. With 273 IPOs, 2014 was the most active period of issuance since 406 companies went public in 2000....
CNV: 5.90 (-0.07), SERV: 30.48 (+0.33), ATEN: 4.14 (-0.09), CRCM: 7.98 (-0.07), PANW: 135.27 (+2.26), CDW: 37.03 (+0.63), W: 21.96 (-1.01), Q: 63.31 (+0.06), VRNS: 37.34 (+0.60), CFG: 25.45 (+0.12), AXTA: 25.26 (-0.38), SYF: 32.80 (-0.81), PGRE: 18.54 (-0.11), SC: 22.11 (+0.38), GPRO: 45.27 (-0.02), JMEI: 12.67 (+0.31), HABT: 30.87 (+0.10), CSLT: 9.19 (+0.13), COUP: 11.06 (-0.07), ZTS: 45.46 (-0.33), ZOES: 31.34 (+0.22), MOLG: 2.46 (+0.03), IMS: 25.68 (+0.22), PLAY: 29.51 (-0.12), JD: 26.23 (-0.27), PAYC: 32.37 (-0.71), BABA: 89.05 (+1.95)
Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Dec 24, 4:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday December 23. Navigator Holdings (NYSE: NVGS ) Has Been Unfairly Punished . Other stock mentioned: Transocean (NYSE: RIG ) With the surge in stocks, it...
RH: 86.77 (-1.55), GD: 137.61 (-0.54), LMT: 196.95 (-0.53), HON: 104.38 (+0.88), RTN: 107.03 (-0.37), NOC: 167.14 (-0.15), KMB: 111.00 (+0.82), XOM: 93.37 (+1.00), IBB: 323.46 (+3.04), VSAT: 62.71 (+0.53), NVGS: 17.48 (-0.06), JACK: 87.12 (-1.00), RIG: 19.05 (+0.42), Q: 63.31 (+0.06), COST: 147.10 (-0.66), WAG: 76.05 (-0.49), ETN: 72.55 (+0.90), MDSO: 46.58 (+1.48), DIS: 104.17 (+0.59), WFC: 55.33 (+0.47), PLKI: 61.07 (+0.44), BA: 149.73 (+1.64), DENN: 10.68 (+0.03), CBRL: 130.79 (-0.16), GILD: 101.90 (+1.10), CVX: 112.78 (+1.92)
Jim Cramer's Top Stock Picks: BA MMM ISIS Q
at The Street - Fri Dec 19, 5:00AM CST
Cramer says Isis Pharmaceuticals is the next hot biotech and he's a big fan of drug testing provider Quintiles.
MMM: 165.94 (+0.03), Q: 63.31 (+0.06), ISIS: 63.86 (-0.43), BA: 149.73 (+1.64)
Quintiles Transnational Holdings (Q) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 10:50AM CST
Q: 63.31 (+0.06)
Quintiles Transnational Holdings beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 5:12AM CST
Q: 63.31 (+0.06)
Quintiles 4th Quarter 2014 Results and 2015 Guidance
Business Wire - Thu Feb 12, 5:01AM CST
--9.3% constant currency service revenue growth compared to the fourth quarter of 2013
Q: 63.31 (+0.06)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:30PM CST
NLSN: 45.59 (+2.02), RTIX: 5.54 (+0.19), AAP: 150.16 (-1.26), JAH: 51.18 (+0.18), LMNS: 10.80 (+0.57), THS: 80.00 (-1.57), RWLK: 17.40 (-0.77), CAB: 53.55 (+1.23), FAF: 37.00 (+0.10), HSP: 87.35 (unch), PNK: 25.64 (-0.35), MFA: 7.89 (unch), SPW: 87.37 (-2.81), MFC: 17.31 (+0.27), HIMX: 8.04 (+0.28), LNCE: 30.72 (-0.25), TIME: 24.84 (+0.35), AVP: 9.08 (+0.39), INCY: 75.94 (+0.28), NNN: 41.00 (+0.20), NWE: 53.61 (-0.85), COR: 48.08 (+1.08), MHFI: 102.19 (unch), NCI: 14.99 (-0.01), BWA: 60.17 (-1.21), HERO: 0.92 (+0.02), NRP: 7.86 (-0.45), STC: 37.85 (+0.23), AB: 27.17 (+0.47), CPLA: 65.23 (-1.37), TU: 34.83 (+0.01), IFF: 116.96 (+2.19), GNC: 48.11 (-0.55), MINI: 40.62 (-0.83), ACOR: 36.14 (-0.51), CVE: 19.42 (-0.29), SNI: 73.00 (+0.39), CCE: 43.69 (-0.66), K: 63.20 (-0.10), DPS: 76.95 (-1.35), BG: 82.22 (+1.78), AAWW: 48.01 (+0.44), Q: 63.31 (+0.06), SHPG: 239.82 (+6.11), MANU: 17.20 (-0.21), MPEL: 27.54 (+0.78), APA: 67.05 (+2.47), DBD: 35.82 (+1.07), MPW: 14.64 (+0.14), HE: 33.14 (-0.22), RYN: 28.02 (-1.15), CS: 23.65 (+0.23), PDS: 6.04 (+0.12), ANR: 1.27 (+0.03), SON: 46.65 (-0.79), SKYW: 13.84 (+1.88), LPNT: 69.04 (-0.06), RDN: 16.10 (-0.43), MDWD: 7.22 (+0.17), SCOR: 53.35 (-1.10), FLO: 21.68 (+0.38)
Quintiles Works with NFL to Track Injuries and Understand Trends
Business Wire - Tue Feb 10, 7:01AM CST
Quintiles, the world's largest biopharmaceutical services company, is working with the National Football League (NFL) to track player injuries and understand trends in injury occurrence.
Q: 63.31 (+0.06)
Quintiles Continues Governance Transition Plan
Business Wire - Fri Feb 06, 7:00AM CST
Quintiles Transnational Holdings Inc. ("Quintiles" or the "Company"
(NYSE: Q) announced today that its Board and principal shareholders have reached agreement on a governance plan to transition the Company's Board of Directors and its committees to comply with NYSE criteria as a non-controlled company. Q: 63.31 (+0.06)
Dr. John Leonard Elected to Quintiles Transnational Holdings Inc. Board of Directors
Business Wire - Fri Feb 06, 7:00AM CST
Quintiles Transnational Holdings Inc. ("Quintiles" or the "Company"
(NYSE: Q) announced today that Dr. John Leonard, MD, has been appointed to its Board of Directors, effective immediately. Dr. Leonard will also serve as a member of the Audit and Governance Committees of the Board. Q: 63.31 (+0.06)
IBB Is +34% For 1 Year And +7.31% For 2015 - But What Are The Risks?
Reuben Sushman - at Seeking Alpha - Fri Jan 30, 9:07AM CST
VRTX: 113.66 (+4.03), Q: 63.31 (+0.06), IBB: 323.46 (+3.04), CELG: 115.88 (+0.16)
Icon, A Leader In Its Industry, Builds A Base
at Investor's Business Daily - Tue Jan 27, 5:12PM CST
New drugs require clinical trials and those trials increasingly have taken place on an international stage. Many top drug developers outsource an increasing share of trials to companies like Icon (ICLR). Based in Dublin, Icon is one of the top five...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), LH: 116.90 (+0.06), ICLR: 60.01 (+0.38), CVD: 107.08 (+0.05)
Investigator Initiated Trials is Topic of New Handbook Sponsored by Quintiles
Business Wire - Thu Jan 22, 9:00PM CST
Quintiles today announced the launch of a handbook to guide physicians in the conduct of investigator initiated clinical trials. Top clinical researchers from academia and industry across Asia-Pacific joined Quintiles' experts in contributing to and editing the handbook, which Quintiles sponsored as part of its ongoing efforts to enhance clinical research globally and create a healthier world.
Q: 63.31 (+0.06)
Quintiles' Fourth Quarter 2014 Earnings Call Scheduled for Thursday, February 12th
Business Wire - Mon Jan 19, 7:00AM CST
Quintiles Transnational Holdings Inc. (NYSE:Q) will release its fourth-quarter 2014 financial results Thursday, February 12, 2015 prior to its quarterly earnings call at 8:00 a.m. EST.
Q: 63.31 (+0.06)
Expression Analysis Announces 2014 Grant Winners
Business Wire - Thu Jan 15, 7:00AM CST
Expression Analysis (EA), a Quintiles company, today announced the winners of a grant program that provides scientists with leading-edge products and services to advance genomics research. In this sixth year of the program, EA and co-sponsor, Illumina, awarded two fully funded research grants to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded (FFPE) tumor samples - a largely untapped data pool that can help enhance researchers' understanding of cancer biology.
Q: 63.31 (+0.06)
Insider Trading Alert - AHS, Q And VLGEA Traded By Insiders
at The Street - Mon Jan 12, 9:15AM CST
Stocks with insider trader activity include AHS, Q and VLGEA
Q: 63.31 (+0.06), AHS: 20.56 (-0.34), VLGEA: 28.17 (-0.08)
Quintiles Transitional (Q) Stock Gains on Mixed Analyst Report
at The Street - Fri Jan 02, 8:38AM CST
Quintiles Transitional Holdings (Q) shares are up after analysts at Keybanc reiterated their 'hold' rating ahead of the release of the company's 2015 guidance.
Q: 63.31 (+0.06)
Will Health Yield Wealth For Recent IPO INC Research?
at Investor's Business Daily - Wed Dec 31, 3:53PM CST
What's the prescription for stirring up investor enthusiasm in the IPO market? INC Research Holdings (INCR) may have found the answer. INC is a contract research organization, or CRO, which provides phase one to phase four clinical development...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), INCR: 24.19 (-0.45), ILMN: 198.54 (+1.81), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
Recent IPO PRA Health Sciences Finds Growth In Buyout
at Investor's Business Daily - Tue Dec 30, 4:16PM CST
Recent IPO PRA Health Sciences may have gotten a tepid reception from investors out of the gate. But the global contract research organization, or CRO, has been making up for lost time ever since. PRA (PRAH) went public in November at $18, below...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), INCR: 24.19 (-0.45), ILMN: 198.54 (+1.81), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
Grab 2015 Gains With These 5 Health Care Trades: Intuitive Surgical, Receptos and More
at The Street - Tue Dec 30, 7:32AM CST
The health care sector is showing strong vitals as we head into 2015. Here's a closer technical look at five health stocks that look ready for breakout gains.
ISRG: 510.73 (+3.02), Q: 63.31 (+0.06), THC: 44.30 (+0.75), RCPT: 115.83 (-0.66), BRKR: 18.77 (-0.02)
Renaissance Capital's 2014 U.S. IPO Annual Review
Renaissance Capital IPO Research - at Seeking Alpha - Fri Dec 26, 3:53AM CST
2014 U.S. IPO Market Has Another Record Year Over the last year, the US IPO market set a 14-year record against a mostly low-volatility backdrop. With 273 IPOs, 2014 was the most active period of issuance since 406 companies went public in 2000....
CNV: 5.90 (-0.07), SERV: 30.48 (+0.33), ATEN: 4.14 (-0.09), CRCM: 7.98 (-0.07), PANW: 135.27 (+2.26), CDW: 37.03 (+0.63), W: 21.96 (-1.01), Q: 63.31 (+0.06), VRNS: 37.34 (+0.60), CFG: 25.45 (+0.12), AXTA: 25.26 (-0.38), SYF: 32.80 (-0.81), PGRE: 18.54 (-0.11), SC: 22.11 (+0.38), GPRO: 45.27 (-0.02), JMEI: 12.67 (+0.31), HABT: 30.87 (+0.10), CSLT: 9.19 (+0.13), COUP: 11.06 (-0.07), ZTS: 45.46 (-0.33), ZOES: 31.34 (+0.22), MOLG: 2.46 (+0.03), IMS: 25.68 (+0.22), PLAY: 29.51 (-0.12), JD: 26.23 (-0.27), PAYC: 32.37 (-0.71), BABA: 89.05 (+1.95)
Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Dec 24, 4:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday December 23. Navigator Holdings (NYSE: NVGS ) Has Been Unfairly Punished . Other stock mentioned: Transocean (NYSE: RIG ) With the surge in stocks, it...
RH: 86.77 (-1.55), GD: 137.61 (-0.54), LMT: 196.95 (-0.53), HON: 104.38 (+0.88), RTN: 107.03 (-0.37), NOC: 167.14 (-0.15), KMB: 111.00 (+0.82), XOM: 93.37 (+1.00), IBB: 323.46 (+3.04), VSAT: 62.71 (+0.53), NVGS: 17.48 (-0.06), JACK: 87.12 (-1.00), RIG: 19.05 (+0.42), Q: 63.31 (+0.06), COST: 147.10 (-0.66), WAG: 76.05 (-0.49), ETN: 72.55 (+0.90), MDSO: 46.58 (+1.48), DIS: 104.17 (+0.59), WFC: 55.33 (+0.47), PLKI: 61.07 (+0.44), BA: 149.73 (+1.64), DENN: 10.68 (+0.03), CBRL: 130.79 (-0.16), GILD: 101.90 (+1.10), CVX: 112.78 (+1.92)
Jim Cramer's Top Stock Picks: BA MMM ISIS Q
at The Street - Fri Dec 19, 5:00AM CST
Cramer says Isis Pharmaceuticals is the next hot biotech and he's a big fan of drug testing provider Quintiles.
MMM: 165.94 (+0.03), Q: 63.31 (+0.06), ISIS: 63.86 (-0.43), BA: 149.73 (+1.64)
